Vivasure Medical to exhibit at TCT 2017

Vivasure Medical will exhibit its PerQseal® vascular technology at TCT 2017, which will take place at Colorado Convention Center in Denver, CO, USA, from October 29th - November 2nd. Vivasure will be at booth 4134 on the main exhibition floor. More...

20 October 2017

Vivasure Enrolls First Patient in Frontier IV Clinical Trial

Vivasure Medical is pleased to announce the successful enrollment of the first patient in the Frontier IV clinical study, a non-randomized multicenter international trial, designed to expand the indications of its proprietary PerQseal® large arteriotomy closure technology. The patient was enrolled by Dr. Peter Crean at the Blackrock Clinic, Dublin, Ireland. More...

13 October 2017

Vivasure Medical to present their PerQseal technology at PCR London Valves 2017

Vivasure Medical is pleased to announce that Dr. Michael Laule, from the Charite Hospital in Berlin Germany, will deliver a presentation on its PerQseal technology on Monday 25th September at 17:20h during the session “Percutaneous valve intervention: new devices, new approaches” at PCR London Valves, which will be held at London’s ExCel from 24th -26th September2017. Vivasure will also be exhibiting at the congress. More...

19 September 2017